4.4500
-0.3800
(-7.87%)
At close: January 10 at 4:00:01 PM EST
4.3513
-0.10
(-2.22%)
After hours: 7:39:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-280,427.0000
-300,316.0000
-229,490.0000
-74,406.0000
-102,489.0000
Investing Cash Flow
-10,403.0000
257,634.0000
-188,745.0000
-479,511.0000
81,672.0000
Financing Cash Flow
291,271.0000
34,753.0000
289,910.0000
388,090.0000
426,509.0000
End Cash Position
154,476.0000
146,443.0000
154,372.0000
282,697.0000
448,524.0000
Capital Expenditure
-2,136.0000
-4,126.0000
-9,062.0000
-3,471.0000
-1,931.0000
Issuance of Capital Stock
286,810.0000
30,281.0000
284,744.0000
382,210.0000
425,293.0000
Free Cash Flow
-282,563.0000
-304,442.0000
-238,552.0000
-77,877.0000
-104,420.0000
12/31/2020 - 7/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
KYMR Kymera Therapeutics, Inc.
38.17
-5.80%
ARVN Arvinas, Inc.
18.62
-6.05%
SWTX SpringWorks Therapeutics, Inc.
43.00
+6.20%
TNGX Tango Therapeutics, Inc.
2.9250
-9.44%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
ZNTL Zentalis Pharmaceuticals, Inc.
2.7500
-1.08%
NUVB Nuvation Bio Inc.
2.7800
-7.64%
INZY Inozyme Pharma, Inc.
1.9950
-28.75%
IGMS IGM Biosciences, Inc.
2.0900
-66.29%